BackNutex Health Overview

Nutex Health Other Current Liabilities

Track Nutex Health's other current liabilities ($96M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$96.12M
274.12% YoYΔ $70.43M vs prior year quarter

Peer average

Loading

Nutex Health Other Current Liabilities History

Loading

Nutex Health vs. peers: Other Current Liabilities Comparison

Loading

Nutex Health Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Nutex Health (NUTX) FAQ

Nutex Health posts a other current liabilities of $96M as of March 2026. That compares with $26M in the prior-year period — up 274.1% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Nutex Health's other current liabilities was $26M. The latest reading is $96M — a 274.1% year-over-year increase (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Other Current Liabilities is one piece of Nutex Health's financial statement story. At $96M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for NUTX's other current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Nutex Health's other metric pages and overview cover the third.

Judging Nutex Health against Consumer Staples peers is usually better than using a market-wide rule of thumb. Business models inside Consumer Staples are more comparable, which makes gaps in other current liabilities easier to interpret. Start with $96M here, then scan peer and history charts to see if the gap is persistent.